Intronix Technologies Corporation will unveil “Myoguide”, their new injection site targeting, handheld device, at MEDICA 2009, November 18-21 in Düsseldorf, Germany.
Myoguide presents a comprehensive integrated system that was developed for clinicians injecting neuromodulators ( Botox©, Myoblock©,Dysport©), for the management of pain,movement disorders, spastic musclemanagement and cosmetic applications
Clinicians use Myoguide to locate areas of hyperactive muscle fibers for treatment. These sites are often the source of pain and other hidden disorders. This multifunction device includes a single-channel EMG amplifier with stimulator, signal display with analysis, and EMG audio.